Published in Pharmacol Biochem Behav on March 01, 1986
Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem (1999) 1.92
Comparison of nicotine oral consumption and baseline anxiety measures in adolescent and adult C57BL/6J and C3H/Ibg mice. Behav Brain Res (2012) 0.81
Genetic matters: thirty years of progress using mouse models in nicotinic research. Biochem Pharmacol (2013) 0.78
Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis. Genetics (2013) 0.76
CD-1 mice Show Individual Differences in Nicotine Preference in a Modified Two-Bottle Oral Self-Administration Model. Front Psychiatry (2012) 0.76
Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds. Neuropharmacology (2014) 0.75
A method for fine mapping quantitative trait loci in outbred animal stocks. Proc Natl Acad Sci U S A (2000) 5.46
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem (1994) 3.65
Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene. Cell (1983) 3.62
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A (1997) 3.26
A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev (1997) 3.18
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet (1999) 2.69
VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci U S A (1997) 2.34
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci (1992) 2.29
A simple genetic basis for a complex psychological trait in laboratory mice. Science (1995) 2.06
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther (1983) 2.03
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Why some people smoke and others do not: new perspectives. J Consult Clin Psychol (1993) 1.88
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Identification and sequence analysis of the 5' end of the major chicken vitellogenin gene. Nucleic Acids Res (1984) 1.64
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther (1999) 1.61
Modular regulation of cGATA-5 gene expression in the developing heart and gut. Dev Biol (2000) 1.57
Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther (2010) 1.57
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol (2000) 1.46
Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem (1992) 1.45
Chicken vitellogenin gene-binding protein, a leucine zipper transcription factor that binds to an important control element in the chicken vitellogenin II promoter, is related to rat DBP. Mol Cell Biol (1991) 1.44
Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology (1996) 1.41
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther (1985) 1.39
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther (1998) 1.32
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol (2000) 1.31
The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron (2001) 1.28
Major differences between WHV and HBV in the regulation of transcription. Virology (1997) 1.27
Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther (1993) 1.24
Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) (1996) 1.23
Genetic influences on nicotine responses. Pharmacol Biochem Behav (1989) 1.22
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem (2001) 1.21
Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. Pharmacogenetics (2001) 1.19
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther (1991) 1.19
Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther (1986) 1.19
A GATA-6 gene heart-region-specific enhancer provides a novel means to mark and probe a discrete component of the mouse cardiac conduction system. Mech Dev (2001) 1.17
Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol (1982) 1.15
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. J Pharmacol Exp Ther (2007) 1.10
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci (2000) 1.09
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol (1986) 1.09
DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic region. Mol Cell Biol (1995) 1.09
Semihistone protein A24 replaces H2A as an integral component of the nucleosome histone core. Proc Natl Acad Sci U S A (1979) 1.08
A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. J Pharmacol Exp Ther (1993) 1.07
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J Pharmacol Exp Ther (1996) 1.06
Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem (1997) 1.05
Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav Neurosci (1997) 1.05
Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. J Neurosci (1998) 1.05
Subfamilies of CR1 non-LTR retrotransposons have different 5'UTR sequences but are otherwise conserved. Gene (2001) 1.05
Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. J Virol (1994) 1.04
An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res Bull (1989) 1.03
Chicken repeat 1 (CR1) elements, which define an ancient family of vertebrate non-LTR retrotransposons, contain two closely spaced open reading frames. Gene (1997) 1.03
An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci (1999) 1.03
Evidence that chicken CR1 elements represent a novel family of retroposons. Mol Cell Biol (1989) 1.02
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther (1998) 1.02
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther (1996) 1.02
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res (1999) 1.02
Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther (1991) 1.02
Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. Alcohol Clin Exp Res (1999) 1.00
Characterization of the core promoter and enhancer of duck hepatitis B virus. Virology (1991) 1.00
Common role for each of the cGATA-4/5/6 genes in the regulation of cardiac morphogenesis. Dev Genet (1998) 0.99
Chromatin structural transitions and the phenomenon of vitellogenin gene memory in chickens. Mol Cell Biol (1986) 0.99
Tolerance to and cross tolerance between ethanol and nicotine. Pharmacol Biochem Behav (1988) 0.99
Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J Neurochem (1994) 0.98
Genetic influence upon phenobarbital-induced increase in rat liver supernatant aldehyde dehydrogenase activity. J Biol Chem (1972) 0.98
Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacol Biochem Behav (1994) 0.97
Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons. Brain Res (2001) 0.97
Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther (1993) 0.97
Isolation of chicken vitellogenin I and III cDNAs and the developmental regulation of five estrogen-responsive genes in the embryonic liver. Genes Dev (1988) 0.97
Role of liver cytosolic aldehyde dehydrogenase isozymes in control of blood acetaldehyde concentrations. J Pharmacol Exp Ther (1977) 0.96
The roles of H1, the histone core and DNA length in the unfolding of nucleosomes at low ionic strength. Nucleic Acids Res (1980) 0.96
Differential effects of central nervous system depressants in long-sleep and short-sleep mice. J Pharmacol Exp Ther (1986) 0.96
Mutational studies reveal a complex set of positive and negative control elements within the chicken vitellogenin II promoter. Mol Cell Biol (1991) 0.95
Specific histone-histone contacts are ruptured when nucleosomes unfold at low ionic strength. Biochemistry (1979) 0.95
Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning. Genes Brain Behav (2008) 0.94